Hoogerbrugge N - Search Results

1

PTEN Hamartoma Tumor Syndrome and Immune Dysregulation.

Eissing M, Ripken L, Schreibelt G, Westdorp H, Ligtenberg M, Netea-Maier R, Netea MG, de Vries IJM, Hoogerbrugge N. Eissing M, et al. Among authors: hoogerbrugge n. Transl Oncol. 2019 Feb;12(2):361-367. doi: 10.1016/j.tranon.2018.11.003. Epub 2018 Nov 30. Transl Oncol. 2019. PMID: 30504085 Free PMC article. Review.

2

High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.

Hoogerbrugge N, Bult P, de Widt-Levert LM, Beex LV, Kiemeney LA, Ligtenberg MJ, Massuger LF, Boetes C, Manders P, Brunner HG. Hoogerbrugge N, et al. J Clin Oncol. 2003 Jan 1;21(1):41-5. doi: 10.1200/JCO.2003.02.137. J Clin Oncol. 2003. PMID: 12506168 Free article.

3

Very low incidence of microsatellite instability in rectal cancers from families at risk for HNPCC.

Hoogerbrugge N, Willems R, Van Krieken HJ, Kiemeney LA, Weijmans M, Nagengast FM, Arts N, Brunner HG, Ligtenberg MJ. Hoogerbrugge N, et al. Clin Genet. 2003 Jan;63(1):64-70. doi: 10.1034/j.1399-0004.2003.630110.x. Clin Genet. 2003. PMID: 12519374

4

Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis.

Kievit W, de Bruin JH, Adang EM, Ligtenberg MJ, Nagengast FM, van Krieken JH, Hoogerbrugge N. Kievit W, et al. Among authors: hoogerbrugge n. Clin Genet. 2004 Apr;65(4):308-16. doi: 10.1111/j.1399-0004.2004.00220.x. Clin Genet. 2004. PMID: 15025724

5

More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon.

van den Bos M, van den Hoven M, Jongejan E, van der Leij F, Michels M, Schakenraad S, Aben K, Hoogerbrugge N, Ligtenberg M, van Krieken JH. van den Bos M, et al. Among authors: hoogerbrugge n. Am J Surg Pathol. 2004 Jun;28(6):706-11. doi: 10.1097/01.pas.0000126720.49083.11. Am J Surg Pathol. 2004. PMID: 15166662

6

Cost effectiveness of a new strategy to identify HNPCC patients.

Kievit W, de Bruin JH, Adang EM, Severens JL, Kleibeuker JH, Sijmons RH, Ruers TJ, Nagengast FM, Vasen HF, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Kievit W, et al. Among authors: hoogerbrugge n. Gut. 2005 Jan;54(1):97-102. doi: 10.1136/gut.2004.039123. Gut. 2005. PMID: 15591512 Free PMC article.

7

Surveillance of women at high risk for hereditary ovarian cancer is inefficient.

Oei AL, Massuger LF, Bulten J, Ligtenberg MJ, Hoogerbrugge N, de Hullu JA. Oei AL, et al. Among authors: hoogerbrugge n. Br J Cancer. 2006 Mar 27;94(6):814-9. doi: 10.1038/sj.bjc.6603015. Br J Cancer. 2006. PMID: 16495917 Free PMC article.

8

Optimizing the detection of hereditary non-polyposis colorectal cancer: an update.

De Bruin JH, Ligtenberg MJ, Nagengast FM, Adang EM, Van Krieken JH, Hoogerbrugge N. De Bruin JH, et al. Among authors: hoogerbrugge n. Scand J Gastroenterol Suppl. 2006;(243):146-52. doi: 10.1080/00365520600664508. Scand J Gastroenterol Suppl. 2006. PMID: 16782634 Review.

9

Numerous high-risk epithelial lesions in familial breast cancer.

Hoogerbrugge N, Bult P, Bonenkamp JJ, Ligtenberg MJ, Kiemeney LA, de Hullu JA, Boetes C, Niermeijer MF, Brunner HG. Hoogerbrugge N, et al. Eur J Cancer. 2006 Oct;42(15):2492-8. doi: 10.1016/j.ejca.2006.05.027. Eur J Cancer. 2006. PMID: 16908132

10

Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of 'easy to apply' probability models.

Bodmer D, Ligtenberg MJ, van der Hout AH, Gloudemans S, Ansink K, Oosterwijk JC, Hoogerbrugge N. Bodmer D, et al. Among authors: hoogerbrugge n. Br J Cancer. 2006 Sep 18;95(6):757-62. doi: 10.1038/sj.bjc.6603306. Epub 2006 Aug 15. Br J Cancer. 2006. PMID: 16909138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

334 results

Search Page